trial · primary record
HX9428 tablet
Wet Age-related Macular Degeneration (AMD)
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 198 |
| Primary completion | 2029-01-07 |
| Primary endpoint | Phase I : Dose-Limiting Toxicity (DLT) |
| Registry ID | NCT07185841 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:49.545Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07185841
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.